ML
EGRX

McAdam LLC’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

McAdam LLC’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-100
Closed -$8K – 749
2018
Q2 		$8K Sell
100
-300
-75% -$24K ﹤0.01% 354
2018
Q1 		$21K Buy
+400
New +$21K 0.01% 239